Chief Science OfficerResearch & Development, BioventusDurham, North Carolina, United States
Disclosure information not submitted.
SP13F - EXOGEN Mitigates Risk of Fifth Metatarsal Fracture Nonunion: Results of a Novel Real-world Clinical Study
Tuesday, August 24, 20215:15 PM – 6:30 PM US Eastern Time